Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis

Archive ouverte

de Tayrac, Marie | Roth, Marie-Paule | Jouanolle, Anne-Marie | Coppin, Hélène | Le Gac, Gérald | Piperno, Alberto | Férec, Claude | Pelucchi, Sara | Scotet, Virginie | Bardou-Jacquet, Edouard | Ropert, Martine | Bouvet, Régis | Génin, Emmanuelle | Mosser, Jean | Deugnier, Yves

Edité par CCSD ; Elsevier -

International audience. Background & aims - Hereditary hemochromatosis (HH) is the most common form of genetic iron loading disease. It is mainly related to the homozygous C282Y/C282Y mutation in the HFE gene that is, however, a necessary but not a sufficient condition to develop clinical and even biochemical HH. This suggests that modifier genes are likely involved in the expressivity of the disease. Our aim was to identify such modifier genes. Methods - We performed a genome-wide association study (GWAS) using DNA collected from 474 unrelated C282Y homozygotes. Associations were examined for both quantitative iron burden indices and clinical outcomes with 534,213 single nucleotide polymorphisms (SNP) genotypes, with replication analyses in an independent sample of 748 C282Y homozygotes from four different European centres. Results - One SNP met genome-wide statistical significance for association with transferrin concentration (rs3811647, GWAS p value of 7×10(-9) and replication p value of 5×10(-13)). This SNP, located within intron 11 of the TF gene, had a pleiotropic effect on serum iron (GWAS p value of 4.9×10(-6) and replication p value of 3.2×10(-6)). Both serum transferrin and iron levels were associated with serum ferritin levels, amount of iron removed and global clinical stage (p<0.01). Serum iron levels were also associated with fibrosis stage (p<0.0001). Conclusions - This GWAS, the largest one performed so far in unselected HFE-associated HH (HFE-HH) patients, identified the rs3811647 polymorphism in the TF gene as the only SNP significantly associated with iron metabolism through serum transferrin and iron levels. Because these two outcomes were clearly associated with the biochemical and clinical expression of the disease, an indirect link between the rs3811647 polymorphism and the phenotypic presentation of HFE-HH is likely.

Suggestions

Du même auteur

Catégorisation des glioblastomes : typologie et profilage du génome. [Classification of glioblastoma and genome profiling].

Archive ouverte | de Tayrac, Marie | CCSD

International audience

GNPAT variant associated with severe iron overload in HFE hemochromatosis

Archive ouverte | Bardou-Jacquet, Edouard | CCSD

International audience. no abstract

Biomarkers for the prognosis and high-grade glioma clinical outcome

Archive ouverte | Mosser, Jean | CCSD

The present invention relates to the identification and use of biomarkers with clinical relevance to high grade gliomas (HGGs). In particular, the invention provides the identity of four genes, CHAF1B, PDLIM4, EDNRB and HJURP, who...

Chargement des enrichissements...